Oct 29, 2025 · Browse our GLP-1 drug list of incretin mimetics, including: Ozempic, Wegovy, and Rybelsus. Compare doses, side effects, user reviews, and more.

Incretin mimetic Incretin mimetic can refer to any drug that mimics the actions of one or more incretin hormones. They are used for type 2 diabetes. [1][2] Specific incretin mimetics include: Dipeptidyl …

Mar 2, 2022 · These drugs work by mimicking the incretin hormones that the body usually produces naturally to stimulate the release of insulin in response to a meal.

Oct 2, 2023 · Incretin mimetics are medications that mimic incretin hormones. They’re currently approved for Type 2 diabetes or chronic weight management in certain people. Most incretin …

Aug 14, 2025 · Incretin mimetics are a newer class of antidiabetic drugs that work by enhancing the body’s natural incretin hormones. These hormones regulate insulin secretion, reduce glucagon …

Incretin mimetics are a new class of antidiabetes drugs which involve modulation of the incretin system. They bind to and activate glucagon-like peptide-1 (GLP-1) receptors on pancreatic beta-cells …

Incretin mimetics are agents that act like incretin hormones such as glucagon-like peptide-1 (GLP-1). They bind to GLP-1 receptors and stimulate glucose dependent insulin release, therefore act as …

Nov 1, 2009 · Treatment with GLP-1 receptor agonists (“incretin mimetics”) and DPP-4 inhibitors (“incretin enhancers”) are based on antidiabetic properties of insulinotropic gut hormones (“incretins”).

Jan 20, 2026 · Incretin mimetics, or GLP-1 receptor agonists, are a class of medications used to treat type 2 diabetes (off-label for type 1). They mimic the action of incretins, which are natural hormones …

Jul 19, 2025 · Incretin mimetics are medications that replicate the function of natural gut hormones called incretins, which the body releases after food is consumed. By copying the actions of these …